Attending Education Events is Beneficial to Patients and Clinicians

Video

MPN Hero Dr. Irum Khan discusses how education events for patients with cancer are helpful to both the patient and the clinician.

For patients with cancer, especially those with MPNs, knowledge is power and getting this knowledge on their disease often comes in the form of attending education events or conferences where they can connect with medical professionals and get multiple opinions for free, said Dr. Irum Khan.

Khan, a 2019 MPN Hero, highlighted the importance of educating patients with MPN but also stressed that this education needs to be made accessible to vulnerable patients as well and accommodate for their needs.

In an interview with CURE®, Khan highlighted this and discussed how these events illuminate what is important to patients that clinicians wouldn’t have otherwise known about.

Transcription:

But at the same time, it's also really interesting when patients come up to the podium or anonymously ask their questions, or sometimes just come up and talk about an experience they've had. I think what we think matters, it's humbling to be in the clinic, but we think what matters isn't always what really matters to patients.

A lot of times, there's issues in these outpatient medications and the long term financial burden and toxicity of these and sometimes the dialogue gets really interesting, and a lot of back and forth about how different countries handle this, but I think that just understanding some of the real world problems our patients face is something that I at least get a lot of.

And then you know, patients come up and ask you questions on the side and I always encourage my patients to go to these because in my opinion, it's a way to get like five different medical opinions in one room for free. So, I try and push my patients, and sometimes it's a little challenging because a lot of our patients are minorities and they don't have access to the resources and sometimes for them getting to a faraway suburb is a big deal.

But these foundations have been really great about working with us and trying to make sure we have at least one in sort of what we call the Medical District area of Chicago where we have the county hospital or we have UIC, something in that location so that our patients really can attend.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE